MRNA- BASED CANCER VACCINES TARGETING TUMOR ASSOCIATED MACROPHAGES: REPROGRAMMING THE TUMOR MICROENVIRONMENT FOR ENHANCED IMMUNOTHERAPY
Keywords:
mRNA Vaccine, Tumor-Associated Macrophages, Macrophage Polarization, Tumor Microenvironment, Lipid Nanoparticles, Immunotherapy, Immune Reprogramming, Checkpoint BlockadeAbstract
Cancer immunotherapy is limited by the immunosuppressive tumor microenvironment (TME), largely shaped by tumor-associated macrophages (TAMs). mRNA-based vaccines offer a novel strategy to reprogram TAMs from a tumor-promoting M2 to a tumoricidal M1 phenotype. Delivered via targeted lipid nanoparticles, these vaccines enhance anti-tumor immunity and synergize with checkpoint inhibitors. This approach holds promise for converting “cold” tumors into “hot,” improving outcomes in resistant cancers.
Downloads
How to Cite
JOSE, B. P. P., VISWANATHAN, A., BRAHMA, N., S, V., & KUMAR, D. K. (2025). MRNA- BASED CANCER VACCINES TARGETING TUMOR ASSOCIATED MACROPHAGES: REPROGRAMMING THE TUMOR MICROENVIRONMENT FOR ENHANCED IMMUNOTHERAPY. TPM – Testing, Psychometrics, Methodology in Applied Psychology, 32(S2(2025) : Posted 09 June), 764–767. Retrieved from https://tpmap.org/submission/index.php/tpm/article/view/296
Issue
Section
Articles
License

This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.